Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sangzhi Alkaloids Tablets in Type 2 Diabetes
CTR20220482Phase 4Completed
- Sponsor
- Wuheboao Pharmaceutical
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramulus mori alkaloids in type 2 diabetes mellitus (T2DM), sponsored by Wuheboao Pharmaceutical. Started Mar 2022; status: completed.
02
Drugs
ramulus mori alkaloids
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20220482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220482.